Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

4405 ARTÍCULOS , VIENDO DEL 2926 AL 2940

Safety of Converting From Tetrabenazine to Deutetrabenazine for the Treatment of Chorea

Frank S, Stamler D, Kayson E, Claassen DO, Colcher A, Davis C, Duker A, Eberly S, Elmer L, Furr-Stimming E, Gudesblatt M, Hunter C, Jankovic J, Kostyk SK, Kumar R, Loy C, Mallonee W, Oakes D, Scott BL, Sung V, Goldstein J, Vaughan C, Testa CM; Huntington Study Group/Alternatives for Reducing Chorea in Huntington Disease Investigators.

JAMA Neurol. 2017 Aug 1;74(8):977-982. doi: 10.1001/jamaneurol.2017.1352.

Predicting Prognosis of Psychosis in Huntington's Disease: Case Report and Review of Literature

Kar SK, Shahi MK, Tripathi A, Sharma PK.

J Neurosci Rural Pract. 2017 Jul-Sep;8(3):469-471. doi: 10.4103/jnrp.jnrp_453_16.

Striatal-enriched Tyrosine Protein Phosphatase (STEP) in the Mechanisms of Depressive Disorders

Kulikova E, Kulikov A.

Curr Protein Pept Sci. 2017 Aug 30;18(11):1152-1162. doi: 10.2174/1389203718666170710121532.

The CREST-E study of creatine for Huntington disease: A randomized controlled trial

Hersch SM, Schifitto G, Oakes D, Bredlau AL, Meyers CM, Nahin R, Rosas HD; Huntington Study Group CREST-E Investigators and Coordinators.

Neurology. 2017 Aug 8;89(6):594-601. doi: 10.1212/WNL.0000000000004209. Epub 2017 Jul 12.

The therapeutic implication of a novel SCN2A mutation associated early-onset epileptic encephalopathy with Rett-like features

Liang JS, Lin LJ, Yang MT, Wang JS, Lu JF.

Brain Dev. 2017 Nov;39(10):877-881. doi: 10.1016/j.braindev.2017.06.003. Epub 2017 Jul 11.

MicroRNA: Basic concepts and implications for regeneration and repair of neurodegenerative diseases

Saraiva C, Esteves M, Bernardino L.

Biochem Pharmacol. 2017 Oct 1;141:118-131. doi: 10.1016/j.bcp.2017.07.008. Epub 2017 Jul 11.

Regulatory Roles of Long Non-Coding RNAs in the Central Nervous System and Associated Neurodegenerative Diseases

Quan Z, Zheng D, Qing H.

Front Cell Neurosci. 2017 Jun 30;11:175. doi: 10.3389/fncel.2017.00175. eCollection 2017.

Interrelationships Among Gut Microbiota and Host: Paradigms, Role in Neurodegenerative Diseases and Future Prospects

Caballero-Villarraso J, Galvan A, Escribano BM, Tunez I.

CNS Neurol Disord Drug Targets. 2017;16(8):945-964. doi: 10.2174/1871527316666170714120118.

Moving to the Rhythm with Clock (Circadian) Genes, Autophagy, mTOR, and SIRT1 in Degenerative Disease and Cancer

Maiese K.

Curr Neurovasc Res. 2017;14(3):299-304. doi: 10.2174/1567202614666170718092010.

Clinical Uses of Melatonin in Neurological Diseases and Mental and Behavioural Disorders

Sanchez-Barcelo EJ, Rueda N, Mediavilla MD, Martinez-Cue C, Reiter RJ.

Curr Med Chem. 2017 Nov 20;24(35):3851-3878. doi: 10.2174/0929867324666170718105557.

The spread of prion-like proteins by lysosomes and tunneling nanotubes: Implications for neurodegenerative diseases

Victoria GS, Zurzolo C.

J Cell Biol. 2017 Sep 4;216(9):2633-2644. doi: 10.1083/jcb.201701047. Epub 2017 Jul 19.

NMDAR hypofunction and somatostatin-expressing GABAergic interneurons and receptors: A newly identified correlation and its effects in schizophrenia

Alherz F, Alherz M, Almusawi H.

Schizophr Res Cogn. 2017 Mar 9;8:1-6. doi: 10.1016/j.scog.2017.02.001. eCollection 2017 Jun.

Valbenazine for Tardive Dyskinesia

Freudenreich O, Remington G.

Clin Schizophr Relat Psychoses. 2017 Summer;11(2):113-119.

A review on protein misfolding, aggregation and strategies to prevent related ailments

Shamsi TN, Athar T, Parveen R, Fatima S.

Int J Biol Macromol. 2017 Dec;105(Pt 1):993-1000. doi: 10.1016/j.ijbiomac.2017.07.116. Epub 2017 Jul 23.

Proteostasis of Huntingtin in Health and Disease

Koyuncu S, Fatima A, Gutierrez-Garcia R, Vilchez D.

Int J Mol Sci. 2017 Jul 19;18(7):1568. doi: 10.3390/ijms18071568.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias